SCHEMBL24105867

SCHEMBL24105867

Cc1cccc2c3cccc(-c4ccc(-c5ccccc5)cc4)c3n(C)c12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALKBH5 Q6P6C2 1/20 0.54
▸ FTO Q9C0B1 1/20 0.54
▸ MEN1 O00255 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ HCRTR1 O43613 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.40
▸ PDCD1 Q15116 1/20 0.39
▸ CD274 Q9NZQ7 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.38
▸ BRD4 O60885 2/20 0.38
▸ MAPT P10636 1/20 0.38
▸ ESR1 P03372 1/20 0.37
▸ HSD11B1 P28845 2/20 0.36
▸ NTRK1 P04629 1/20 0.35
▸ DHODH Q02127 1/20 0.35
▸ TYMS P04818 1/20 0.35
▸ ENPP3 O14638 1/20 0.35
▸ ENPP1 P22413 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24105882 0.97 ALKBH5 (0.58) ALKBH5FTOMEN1NPC1HCRTR1
SCHEMBL14931060 0.88 HSD17B10 (0.46) ALKBH5FTOPDCD1CD274HSD17B10
SCHEMBL21156638 0.86 HSD17B10 (0.44) ALKBH5FTOMEN1NPC1RAB9A
SCHEMBL18015005 0.81 ALKBH5 (0.56) ALKBH5FTOKMT2AKDM4EHSD17B10
SCHEMBL26242847 0.80 HSD17B10 (0.41) ALKBH5FTOKDM4EPDCD1CD274
SCHEMBL21157928 0.80 L3MBTL1 (0.44) MEN1NPC1RAB9AKMT2AKDM4E
SCHEMBL14931058 0.80 ALKBH5 (0.72) ALKBH5FTOMEN1NPC1HCRTR1
SCHEMBL21157926 0.79 HSD17B10 (0.40) ALKBH5FTOHSD17B10BRD4HSD11B1
SCHEMBL17030436 0.78 HSD17B10 (0.46) ALKBH5FTOMEN1KMT2AKDM4E
SCHEMBL18160217 0.78 ALKBH5 (0.65) ALKBH5FTOMEN1NPC1HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210388013-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2021-12-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210388013-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES ODC1, OCIAD1, OCIAD2 ALKBH5 1044/4885FTO 69/4885MEN1 1007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback